BCS

Opioid Prescribing Review

Opioid Prescribing Review .

A pharmacist-led opioid prescribing review programme — identifying high-dose and long-duration prescribing, shared-decision-making and structured taper plans. Delivered nationally from the BCS Halifax (Yorkshire) and Chiswick (London) hubs — the only UK dual-hub clinical pharmacy provider.
Talk to us How we start

What you get

What this looks like in practice.

  • High-dose cohort identification
  • Shared decision-making consults
  • Structured taper plans
  • Pain management signposting
  • Outcomes tracked monthly

Also known as.

This service is often referred to as Opioid Prescribing audit, Opioid stewardship, Opioid deprescribing. BCS delivers it as one canonical, ARRS-compliant managed service.

Why BCS

Built for primary care, at scale.

2 hubs
Halifax + Chiswick — unique to BCS
4–6 wks
Typical mobilisation
100%
Supervision evidenced
Monthly
QA-checked reporting

Frequently asked questions — Opioid Prescribing Review.

Is this safe to run pharmacist-led?+

Yes — every taper plan is signed off with the GP and the patient, with safety-netting and step-back protocols documented.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call

By area

Opioid Prescribing Review in your area.

Local landing pages for opioid prescribing review are live for every town and borough in BCS coverage.

All BCS locations →Coverage map →